Filana Therapeutics, Inc. (FLNA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 99.01M |
| Enterprise Value | 3.51M |
| P/E Ratio | -1.18 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.78 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.41 |
| Return On Equity | -0.59 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -936,000 |
| EBITDA | -90.04M |
| Net Income | -90.97M |
| Diluted EPS | -1.88 |
| Total Cash | 82.68M |
| Total Cash/Share | 1.71 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.08 |
| Book Value Per Share | 1.32 |
| 52-Week Change | -50.49 |
| 52-Week High | 4.98 |
| 52-Week Low | 0.67 |
| Moving Average 50 Days | 0.91 |
| Moving Average 200 Days | 1.61 |
| Average Volume | 313,744 |
| Shares Outstanding | 48.31M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | May 10, 2017 |